ChemWatch Material Safety Data Sheet
Date of Issue: Wed 18-Feb-2004
polyurethane urethane moisture cure coating paint floor finish socyanate PROPER SHIPPING NAME
A single pack solvent based moisture curing clear polyurethane coating; Application is by lambswool applicator may also be applied by brush or hand rol er. CONTAINS free organic isocyanate. Mixing and application requires special precautions and use of personal protective gear [APMF]. The use of a quantity of material in an unventilated or confined space may result in increased exposure and an irritating atmosphere developing Before starting consider control of SUPPLIER
Company: Wattyl Australia Pty Limited Address: 4 Steel St Blacktown NSW, 2148 AUSTRALIA Telephone: 132101 Telephone: (+61 2) 9621 6255 Emergency Tel: 1800 039 008 (24 hours) Emergency Tel: +61 3 9573 3112 Fax: 02 9831 2651 Section 2 - HAZARDS IDENTIFICATION
According to the Criteria of NOHSC, and the ADG Code. POISONS SCHEDULE
Limited evidence of a carcinogenic effect. May cause SENSITISATION by inhalation and skin contact. Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic HARMFUL-May cause lung damage if swallowed. Keep away from sources of ignition. No smoking. Keep container in a well ventilated place. Avoid exposure - obtain special instructions before use. To clean the floor and all objects contaminated by this material, use water and This material and its container must be disposed of in a safe way. Keep away from food, drink and animal feeding stuffs. Take off immediately all contaminated clothing. In case of contact with eyes, rinse with plenty of water and contact Doctor or If you feel unwell contact Doctor or Poisons Information Centre. (Show the label In case of accident by inhalation: remove casualty to fresh air and keep at Section 3 - COMPOSITION / INFORMATION ON INGREDIENTS
NAME CAS RN % aromatic polyisocyanate solution 9081-90-7 30-60 residual as toluene diisocyanate 26471-62-5 <0.3 naphtha petroleum, light aromatic solvent 64742-95-6. 30-60 additives <10 Section 4 - FIRST AID MEASURES
• For advice, contact a Poisons Information Centre or a doctor at once. • Urgent hospital treatment is likely to be needed. • If swallowed do NOT induce vomiting. • If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain open airway and prevent aspiration. • Never give liquid to a person showing signs of being sleepy or with reduced • Give water to rinse out mouth, then provide liquid slowly and as much as • Transport to hospital or doctor without delay. If this product comes in contact with the eyes: • Immediately hold eyelids apart and flush the eye continuously with running • Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasional y lifting the upper and lower lids. • Continue flushing until advised to stop by the Poisons Information Centre or a • Transport to hospital or doctor without delay. • Removal of contact lenses after an eye injury should only be undertaken by • Immediately remove all contaminated clothing, including footwear • Flush skin and hair with running water (and soap if available). • Seek medical attention in event of irritation. • If fumes or combustion products are inhaled remove from contaminated area. • Lay patient down. Keep warm and rested. • Prostheses such as false teeth, which may block airway, should be removed, where possible, prior to initiating first aid procedures. • Apply artificial respiration if not breathing, preferably with a demand valve resuscitator, bag-valve mask device, or pocket mask as trained. Perform CPR if NOTES TO PHYSICIAN
For sub-chronic and chronic exposures to isocyanates: • This material may be a potent pulmonary sensitiser which causes bronchospasm even in patients without prior airway hyperreactivity. • Clinical symptoms of exposure involve mucosal irritation of respiratory and gastrointestinal tracts. • Conjunctival irritation, skin inflammation (erythema, pain vesiculation) and gastrointestinal disturbances occur soon after exposure. • Pulmonary symptoms include cough, burning, substernal pain and dyspnoea. • Some cross-sensitivity occurs between different isocyanates. • Noncardiogenic pulmonary edema and bronchospasm are the most serious consequences of exposure. Markedly symptomatic patients should receive oxygen, ventilatory support and an intravenous line. • Treatment for asthma includes inhaled sympathomimetics (epinephrine [adrenalin], terbutaline) and steroids. • Activated charcoal (1 g/kg) and a cathartic (sorbitol, magnesium citrate) may be useful for ingestion. • Mydriatics, systemic analgesics and topical antibiotics (Sulamyd) may be used for corneal abrasions. • There is no effective therapy for sensitised workers. [Ellenhorn and Barceloux; Medical Toxicology] NOTE: Isocyanates cause airway restriction in naive individuals with the degree of response dependant on the concentration and duration of exposure. They induce smooth muscle contraction which leads to bronchoconstrictive episodes. Acute changes in lung function, such as decreased FEV1, may not represent sensitivity. [Karol & Jin, Frontiers in Molecular Toxicology, pp 56-61, 1992]. For acute or short term repeated exposures to petroleum distillates or related hydrocarbons: • Primary threat to life, from pure petroleum distillate ingestion and/or inhalation, is respiratory failure. • Patients should be quickly evaluated for signs of respiratory distress (e.g. cyanosis, tachypnoea, intercostal retraction, obtundation) and given oxygen. Patients with inadequate tidal volumes or poor arterial blood gases (pO2 50 mm Hg) should be intubated. • Arrhythmias complicate some hydrocarbon ingestion and/or inhalation and electrocardiographic evidence of myocardial injury has been reported; intravenous lines and cardiac monitors should be established in obviously symptomatic patients. The lungs excrete inhaled solvents, so that hyperventilation improves clearance. • A chest x-ray should be taken immediately after stabilisation of breathing and circulation to document aspiration and detect the presence of pneumothorax. • Epinephrine (adrenalin) is not recommended for treatment of bronchospasm because of potential myocardial sensitisation to catecholamines. Inhaled cardioselective bronchodilators (e.g. Alupent, Salbutamol) are the preferred agents, with aminophylline a second choice. • Lavage is indicated in patients who require decontamination; ensure use of cuffed endotracheal tube in adult patients. [Ellenhorn and Barceloux: Medical Toxicology] Section 5 - FIRE FIGHTING MEASURES
• Alert Fire Brigade and tell them location and nature of hazard. • May be violently or explosively reactive. • Wear breathing apparatus plus protective gloves. • Prevent, by any means available, spillage from entering drains or water • If safe, switch off electrical equipment until vapour fire hazard removed. • Use water delivered as a fine spray to control fire and cool adjacent area. • Avoid spraying water onto liquid pools. • DO NOT approach containers suspected to be hot. • Cool fire exposed containers with water spray from a protected location. • If safe to do so, remove containers from path of fire. When any large container (including road and rail tankers) is involved in a fire, consider evacuation by 500 metres in all directions. FIRE/EXPLOSION HAZARD
• Moderate fire hazard when exposed to heat or flame. • Vapour forms an explosive mixture with air. • Moderate explosion hazard when exposed to heat or flame. • Vapour may travel a considerable distance to source of ignition. • Heating may cause expansion or decomposition leading to violent rupture of • On combustion, may emit toxic fumes of carbon monoxide (CO). FIRE INCOMPATIBILITY
Avoid any contamination of this material as it is very reactive and any Avoid contamination with oxidising agents i.e. nitrates, oxidising acids, chlorine bleaches, pool chlorine etc. as ignition may result. Avoid reaction with water, alcohols, strong bases, alkalis, metal compounds and detergent solutions. Reacts with water, may generate a large volume of foam, carbon dioxide gas (CO2) and heat. Foaming in confined space may produce pressure. Isocyanates will attack and embrittle some plastics and rubbers. Personal Protective Equipment
• Avoid breathing vapours and contact with skin and eyes. • Control personal contact by using protective equipment. • Contain and absorb small quantities with vermiculite or other absorbent • Col ect residues in a flammable waste container. MAJOR SPILLS
• Clear area of personnel and move upwind. • Alert Fire Brigade and tell them location and nature of hazard. • May be violently or explosively reactive. • Wear breathing apparatus plus protective gloves. • Prevent, by any means available, spillage from entering drains or water • No smoking, naked lights or ignition sources. • Water spray or fog may be used to disperse / absorb vapour. • Contain spill with sand, earth or vermiculite. • Use only spark-free shovels and explosion proof equipment. • Col ect recoverable product into label ed containers for recycling. • Absorb remaining product with sand, earth or vermiculite. • Col ect solid residues and seal in label ed drums for disposal. • Wash area and prevent runoff into drains. • If contamination of drains or waterways occurs, advise emergency services. PROTECTIVE ACTIONS FOR SPILL
From IERG (Canada/Australia) Isolation Distance 25 metres Downwind Protection Distance 300 metres IERG Number 14 FOOTNOTES 1 PROTECTIVE ACTION ZONE is defined as the area in which people are at risk of harmful exposure. This zone assumes that random changes in wind direction confines the vapour plume to an area within 30 degrees on either side of the predominant wind direction, resulting in a crosswind protective action distance equal to the downwind protective action distance. 2 PROTECTIVE ACTIONS should be initiated to the extent possible, beginning with those closest to the spill and working away from the site in the downwind direction. Within the protective action zone a level of vapour concentration may exist resulting in nearly all unprotected persons becoming incapacitated and unable to take protective action and/or incurring serious or irreversible health effects. 3 INITIAL ISOLATION ZONE is determined as an area, including upwind of the incident, within which a high probability of localised wind reversal may expose nearly all persons without appropriate protection to life-threatening concentrations of the material. 4 SMALL SPILLS involve a leaking package of 200 litres (55 US gallons) or less, such as a drum (jerrican or box with inner containers). Larger packages leaking less than 200 litres and compressed gas leaking from a small cylinder are also considered "small spills". LARGE SPILLS involve many small leaking packages or a leaking package of greater than 200 litres, such as a cargo tank, portable tank or a "one-tonne" compressed gas cylinder. 5 Guide 128 is taken from the US DOT emergency response guide book. 6 IERG information is derived from CANUTEC - Transport Canada. Personal Protective Equipment advice is contained in Section 8 of the MSDS. Section 7 - HANDLING AND STORAGE
• Avoid all personal contact, including inhalation. • Wear protective clothing when risk of overexposure occurs. • Prevent concentration in hol ows and sumps. • DO NOT enter confined spaces until atmosphere has been checked. • Avoid smoking, naked lights or ignition sources. • Avoid generation of static electricity. • Avoid contact with incompatible materials. • When handling, DO NOT eat, drink or smoke. • Keep containers securely sealed when not in use. • Avoid physical damage to containers. • Always wash hands with soap and water after handling. • Work clothes should be laundered separately. • Use good occupational work practice. • Observe manufacturer's storing and handling recommendations. • Atmosphere should be regularly checked against established exposure standards Avoid generating and breathing dust. Effective dust extraction and good ventilation is required when using cutting, shaping or sanding tools. Wear a disposable dust mask AS 1715 (1991) class P1 or P2 when machining. SUITABLE CONTAINER
• Packaging as recommended by manufacturer. • Check all containers are clearly label ed and free from leaks. STORAGE INCOMPATIBILITY
Segregate from strong oxidizing agents, amines and acids. • Avoid contamination with water, alkalies and detergent solutions. • Material reacts with water and generates gas, pressurises containers with even • DO NOT reseal container if contamination is suspected. STORAGE REQUIREMENTS
• Store in approved flammable liquid storage area. • No smoking, naked lights/ignition sources. • Store away from incompatible materials in a cool, dry, well-ventilated area. • Protect containers against physical damage and check regularly for leaks. • Observe manufacturer's storing and handling recommendations. Section 8 - EXPOSURE CONTROLS / PERSONAL PROTECTION
OSF=0.029 (aromatic polyisocyanate solution) Exposed individuals are NOT reasonably expected to be warned, by smell, that the Exposure Standard is being exceeded. Odour Safety Factor (OSF) is determined to fall into either Class C, D or E. The Odour Safety Factor (OSF) is defined as: OSF= Exposure Standard (TWA) ppm/ Odour Threshold Value (OTV) ppm
Classification into classes follows:
Class OSF Description
A 550 Over 90% of exposed
individuals are aware by
smell that the Exposure
Standard (TLV-TWA for
example) is being
reached, even when
distracted by working
B 26-550 As "A" for 50-90% of
persons being distracted
C 1-26 As "A" for less than 50%
of persons being
D 0.18-1 10-50% of persons aware
of being tested perceive
by smell that the
Exposure Standard is
being reached
E <0.18 As "D" for less than 10%
of persons aware of being

"Worst Case" computer-aided prediction of vapour components/concentrations:
Composite Exposure Standard for Mixture (TWA) (mg/m³): 6.8419 mg/m³ If the breathing zone concentration of ANY of the components listed below is exceeded, "Worst Case" considerations deem the individual to be overexposed. Component Breathing Zone ppm Breathing Zone mg/m
toluene diisocyanate 0 0.034 0.3
naphtha petroleum, light aromatic 2.72 6.8079 60
Operations which produce a spray/mist or fume/dust, introduce particulates to
the breathing zone.
If the breathing zone concentration of ANY of the components listed below is exceeded, "Worst Case" considerations deem the individual to be overexposed. At the "Composite Exposure Standard for Mixture" (TWA) (mg/m
aromatic polyisocyanate solution 4.3911 38 7

Established occupational exposure limits frequently do not take into
consideration reproductive end points that are clearly below the thresholds for
other toxic effects. Occupational reproductive guidelines (ORGs) have been
suggested as an additional standard. These have been established after a
literature search for reproductive no-observed-adverse effect-level (NOAEL) and
the lowest-observed-adverse-effect-level (LOAEL). In addition the US EPA's
procedures for risk assessment for hazard identification and dose-response
assessment as applied by NIOSH were used in the creation of such limits.
Ingredient ORG UF Endpoint CR Adeq
naphtha petroleum, l 12 mg/m³ 100 D NA -
These exposure guidelines have been derived from a screening level of risk
assessment and should not be construed as unequivocally safe limits. ORGS
represent an 8-hour time-weighted average unless specified otherwise.
CR = Cancer Risk/10000; UF = Uncertainty factor:
TLV believed to be adequate to protect reproductive health:
LOD: Limit of detection
Toxic endpoints have also been identified as:
D = Developmental; R = Reproductive; TC = Transplacental carcinogen
Jankovic J., Drake F.: A Screening Method for Occupational Reproductive
American Industrial Hygiene Association Journal 57: 641-649 (1996)
None assigned. Refer to individual constituents. isocyanates, all ES TWA: 0.02 mg/m³; STEL: 0.07 mg/m³ SENSITISER [WORKSAFE 1995] Many isocyanate compounds cause respiratory and skin sensitisation. Worker exposure by all routes should be carefully controlled and kept to a minimum when handling/mixing components and during spray application. TOLUENE DIISOCYANATE: isocyanates, all as NCO (Mol.Wt: 42.00) ES TWA: 0.02 mg/m³; STEL: 0.07 mg/m³ sensitiser MEL TWA: 0.02 mg/m³; STEL: 0.07 mg/m³ sensitiser Some jurisdictions require that health surveillance be conducted on occupationally exposed workers. This should emphasise: • demography, occupational and medical history and health advice • completion of a standardised respiratory questionnaire • physical examination of the respiratory system and skin • standardised respiratory function tests such as FEV1, FVC and FEV1/FVC. Persons with a history of asthma or other respiratory problems or are known to be sensitised, should not be engaged in any work involving the handling of isocyanates. [CCTRADE-Bayer, APMF] for toluene-2,4-diisocyanate TLV TWA: 0.005 ppm, 0.036 mg/m³; STEL: 0.02ppm, 0.14 mg/m³ A4 NOTE: This substance has been classified by the ACGIH as A4 NOT classifiable as causing Cancer in humans NOTICE OF INTENDED CHANGE for toluene-2,4- and 2,6-diisocyanate TLV TWA 0.005 ppm, 0.036 mg/m³; STEL: 0.02 ppm, 0.14 mg/m³ A4 Sensitiser The odour recognition threshold, 0.05-0.4 ppm in air, is not reliable and being above exposure standard, gives no warning of exposure. NOTE: Detector tubes for toluene diisocyanate, measuring in excess of 0.02 ppm, are commercially available. A substantial proportion of the working population (4.3% to 25%) can be sensitised to TDI at the ES-TWA. Such sensitisation was not limited to highly susceptible individuals and workers often developed symptoms early. Preplacement exams have been unsuccessful in identifying those who may develop sensitisation. Allergy, bronchial asthma and chronic bronchitis sufferers should be excluded from exposure to TDI. Chronic low level exposures below 0.02 ppm have been reported to cause sensitisation. Workers complained of cough, phlegm production, breathlessness and wheezing 2 to 17 years after the last exposure and it is reported that several workers developed chronic bronchitis 40 months after removal from exposure. Effects of TDI appear to be dose-related and there is a threshold (0.005 ppm) below which no respiratory effects are produced by at least the isomer 2,4-TDI. It should be noted that some polyurethane production facilities also emit amines which are the most important cause of respiratory symptoms and occupational asthma. NAPHTHA PETROLEUM, LIGHT AROMATIC SOLVENT: No exposure limits set by NOHSC or ACGIH REL TWA: 25-100 ppm*, 125 mg/m³* [Various Manufacturers] CEL TWA: 50 ppm, 125 mg/m³ PERSONAL PROTECTION

• Safety glasses with side shields; or as required,
• Chemical goggles.
• Contact lenses pose a special hazard; soft lenses may absorb irritants and all
lenses concentrate them.
DO NOT use skin cream unless necessary and then use only minimum amount. Isocyanate vapour may be absorbed into skin cream and this increases hazard. Neoprene rubber gloves. or.
Butyl rubber gloves.
Safety footwear

• Overalls.
• Eyewash unit.
Respiratory protection is required when ANY "Worst Case" vapour-phase concentration is exceeded (see Computer Prediction in "Exposure Standards"). Protection Factor (Min) Half-Face Respirator Full-Face Respirator 10 x ES AB-AUS - AB-PAPR-AUS - 50 x ES - AB-AUS - AB-PAPR-AUS 100 x ES - AB-2 - AB-PAPR-2 ^ - Full-face The local concentration of material, quantity and conditions of use determine the type of personal protective equipment required. For further information consult site specific CHEMWATCH data (if available), or your Occupational Health and Safety Advisor. ENGINEERING CONTROLS
Persons with a history of asthma or other respiratory problems or are known to be sensitised, should not be engaged in any work involving the handling of isocyanates. [CCTRADE-Bayer, APMF]. Local exhaust ventilation usually required. If risk of overexposure exists, wear approved respirator. Correct fit is essential to obtain adequate protection. Supplied-air type respirator may be required in special circumstances. Correct fit is essential to ensure adequate protection. An approved self contained breathing apparatus (SCBA) may be required in some situations. Provide adequate ventilation in warehouse or closed storage area. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Clear flammable liquid with a mild odour; does not mix with water. PHYSICAL PROPERTIES
• Hazardous polymerisation will not occur. Section 11 - TOXICOLOGICAL INFORMATION
Considered an unlikely route of entry in commercial/industrial environments The liquid may produce considerable gastrointestinal discomfort and may be harmful or toxic if swal owed. Ingestion may result in nausea, pain and vomiting. Vomit entering the lungs by aspiration may cause potentially lethal chemical The liquid produces a high level of eye discomfort and is capable of causing pain and severe conjunctivitis. Corneal injury may develop, with possible permanent impairment of vision, if not promptly and adequately treated. The material may be irritating to the eye, with prolonged contact causing inflammation. Repeated or prolonged exposure to irritants may produce The liquid may produce skin discomfort fol owing prolonged contact. Defatting and/or drying of the skin may lead to dermatitis. Toxic effects may result from skin absorption. The material may accentuate any pre-existing dermatitis condition. Bare unprotected skin should not be exposed to this material. Sensitisation may result in allergic dermatitis responses including rash, itching, hives or swel ing of extremities. The vapour/mist may be highly irritating to the upper respiratory tract and lungs; the response may be severe enough to produce bronchitis and pulmonary oedema. Possible neurological symptoms arising from isocyanate exposure include headache, insomnia, euphoria, ataxia, anxiety neurosis, depression and paranoia. Gastrointestinal disturbances are characterised by nausea and vomiting. Pulmonary sensitisation may produce asthmatic reactions ranging from minor breathing difficulties to severe al ergic attacks; this may occur following a single acute exposure or may develop without warning for several hours after exposure. Sensitized people can react to very low doses, and should not be al owed to work in situations al owing exposure to this material. Continued exposure of sensitised persons may lead to possible long term respiratory Inhalation hazard is increased at higher temperatures. Acute effects from inhalation of high concentrations of vapour are pulmonary irritation, including coughing, with nausea; central nervous system depression - characterised by headache and dizziness, increased reaction time, fatigue and If exposure to highly concentrated solvent atmosphere is prolonged this may lead to narcosis, unconsciousness, even coma and possible death. Respiratory sensitisation may result in al ergic/asthma like responses; from coughing and minor breathing difficulties to bronchitis with wheezing, gasping. Inhalation of vapour may aggravate a pre-existing respiratory condition such as CHRONIC HEALTH EFFECTS
Principal routes of exposure are usual y by. inhalation of vapour from the curing material. Prolonged or continuous skin contact with the liquid may cause defatting with drying, cracking, irritation and dermatitis following. Chronic solvent inhalation exposures may result in nervous system impairment Sensitisation reactions may appear suddenly after repeated Sensitisation may give severe responses to very low levels of exposure, in As with any chemical product, contact with unprotected bare skin; inhalation of vapour, mist or dust in work place atmosphere; or ingestion in any form, should be avoided by observing good occupational work practice. Wattyl Estapol SP Gloss Range
No data for Wattyl Estapol SP Gloss Range. AROMATIC POLYISOCYANATE SOLUTION: TOXICITY IRRITATION Oral (rat) LD50: >5000 mg/kg Skin (rabbit): non-irritant/24hr Eye (rabbit): mild-irritant [Bayer] TOLUENE DIISOCYANATE: TOXICITY IRRITATION Oral(rat) LD50: 4130 mg/kg Skin (rabbit):500 mg(open)-SEVERE Inhalation(human) TCLo: 0.5 ppm Eye (rabbit): 100 mg - SEVERE Inhalation(human) TCLo: 0.020 ppm/2 yr Inhalation(human) TCLo: 0.080 ppm Inhalation(woman) TCLo: 0.0003 ppm/8h/5d Inhalation(rat) LC50: 14 ppm/14h Inhalation(rat) LC50: 610mg aerosol/m3/1h* Inhalation(rat) LCLo: 600 ppm/6h *[Bayer] WARNING: This substance has been classified by the IARC as Group 2B Possibly Carcinogenic to Humans. Tenth Annual Report on Carcinogens: Substance anticipated to be Carcinogen [National Toxicology Program: U.S. Dep. of Health & Human Services 2002] CAUTION: TDI is a potent respiratory and skin sensitiser.Sensitized people can react to very low levels of airborne isocyanates. Cross sensitization to other isocyanates can occur. NAPHTHA PETROLEUM, LIGHT AROMATIC SOLVENT: TOXICITY IRRITATION Oral (rat) LD50: >5000 mg/kg * Nil reported Inhalation (rat) LC50: >3670 ppm/8 h * Inhalation (rat) TCLo: 1320 ppm/6h/90D-I * [Devoe] Section 12 - ECOLOGICAL INFORMATION
No data for Wattyl Estapol SP Gloss Range. Refer to data for ingredients, which follows: AROMATIC POLYISOCYANATE SOLUTION: No data for aromatic polyisocyanate solution. TOLUENE DIISOCYANATE: Water pollution class (WGK): 2 - impairment of water quality NAPHTHA PETROLEUM, LIGHT AROMATIC SOLVENT: No data for naphtha petroleum, light aromatic solvent. Section 13 - DISPOSAL CONSIDERATIONS
• Consult manufacturer for recycling options and recycle where possible . • Consult State Land Waste Management Authority for disposal. • Incinerate residue at an approved site. • Recycle containers if possible, or dispose of in an authorised landfill. Section 14 - TRANSPORTATION INFORMATION
This document is copyright. Apart from any fair dealing for the purposes of private study, research, review or criticism, as permitted under the Copyright Act, no part may be reproduced by any process without written permission from


Colorectal Cancer Treatment Options by Stage of Diagnosis The information below will help you understand some of the treatment options available during each stage of colorectal cancer. Stages of Colorectal Cancer Chemotherapy/Biologics Radiation Interventional Radiology determining prognosis Stage II Yes, for rectal and high risk Yes, for rectal cancer. colon

Microsoft word - bio-slim pf i rev0

Water, Glycerin, Escin, Propylene Glycol, PVP, Threonine, Caffeine, Theophylline, Tromethamine, Fucus Vesiculosus Extract, Laminaria Digitata Extract, Equisetum Arvense Extract, Hedera Helix (IVI) Extract. Description BIO-SLIM PF is a natural active ingredient from botanic origin, concentrated, with a slimming effect for the treatment of the local cellulite and improvement of the firmness in t

Copyright © 2010-2014 Metabolize Drugs Pdf